Form 8-K - Current report:
SEC Accession No. 0001193125-20-323073
Filing Date
2020-12-21
Accepted
2020-12-21 16:05:01
Documents
12
Period of Report
2020-12-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d18802d8k.htm   iXBRL 8-K 23720
  Complete submission text file 0001193125-20-323073.txt   145695

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA wve-20201221.xsd EX-101.SCH 3091
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20201221_lab.xml EX-101.LAB 18071
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20201221_pre.xml EX-101.PRE 11399
5 EXTRACTED XBRL INSTANCE DOCUMENT d18802d8k_htm.xml XML 3390
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 201404390
SIC: 2834 Pharmaceutical Preparations